TIDMINS

RNS Number : 4754L

Instem plc

05 September 2023

Amendment: Form 8 (OPD) - Instem plc

The following amended announcement corrects the date in section 1(e) to be 4 September 2023 and the date of disclosure to be 5 September 2023 in the Form 8 (OPD) announcement released at 4.15 p.m. on 5 September 2023 (under RNS no. 4634L)

The full amended version is below:

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:                                                                    Instem plc 
 (b) Owner or controller of interests and short positions disclosed, if different from 1(a):    N/A 
  The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), 
  settlor and beneficiaries must be named. 
                                                                                               ----------------- 
 (c) Name of offeror/offeree in relation to whose relevant securities this form relates:        Instem plc 
  Use a separate form for each offeror/offeree 
                                                                                               ----------------- 
 (d) Is the discloser the offeror or the offeree?                                               OFFEREE 
                                                                                               ----------------- 
 (e) Date position held:                                                                        4 September 2023 
  The latest practicable date prior to the disclosure 
                                                                                               ----------------- 
 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect   N/A 
  of any other party to the offer? 
  If it is a cash offer or possible cash offer, state "N/A" 
                                                                                               ----------------- 
 
   2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 
 Class of relevant security: 
                                                                                      Interests       Short positions 
                                                                                   ---------------  ------------------ 
                                                                                    Number     %      Number       % 
                                                                                   --------  -----  ----------  ------ 
 (1) Relevant securities owned and/or controlled:                                     Nil     0.00      Nil      0.00 
                                                                                   --------  -----  ----------  ------ 
 (2) Cash-settled derivatives:                                                        Nil     0.00      Nil      0.00 
                                                                                   --------  -----  ----------  ------ 
 (3) Stock-settled derivatives (including options) and agreements to 
  purchase/sell:                                                                      Nil     0.00      Nil      0.00 
                                                                                   --------  -----  ----------  ------ 
 
   TOTAL:                                                                             Nil     0.00      Nil      0.00 
                                                                                   --------  -----  ----------  ------ 
 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   (b)        Rights to subscribe for new securities 
 
 Class of relevant security in relation to which subscription right exists:    None 
 Details, including nature of the rights concerned and relevant percentages:   N/A 
                                                                              ----- 
 
   3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE 
 
 Details of any interests, short positions and rights to subscribe (including directors' and 
  other employee options) of any person acting in concert with the party to the offer making 
  the disclosure: 
 
 
        A) Holdings of ordinary shares by directors of Instem plc and their close relatives: 
         Name               No. Ordinary Shares    % of total issued share 
                                           Held    capital carrying voting 
                                                                    rights 
         David Gare*                  1,326,865                      5.79% 
                           --------------------  ------------------------- 
         Phil Reason                    770,714                      3.36% 
                           --------------------  ------------------------- 
         Nigel Goldsmith                 10,000                      0.04% 
                           --------------------  ------------------------- 
 
 
        *Includes holdings of Deborah Walker and Michael Gare and shares held via DG 2008 Discretionary 
        Settlement Trust (of which David Gare and Norma Gare are trustees) 
 
        B) The directors of the Company have the following rights to subscribe for the following relevant 
        Instem plc securities under the share options plans: 
         Name               Date of    Vesting          Latest       Exercise   No. of options 
                              Grant     period     Exercisable    price (GBP)      outstanding 
                                                          Date 
         Phil Reason     26/06/2020    3 years      15/03/2024            Nil           76,000 
                       ------------  ---------  --------------  -------------  --------------- 
         Phil Reason     16/04/2021    3 years      15/03/2025            Nil            4,387 
                       ------------  ---------  --------------  -------------  --------------- 
         Phil Reason     27/09/2021    3 years      15/03/2025            Nil           25,000 
                       ------------  ---------  --------------  -------------  --------------- 
         Phil Reason     02/03/2022    3 years      15/03/2026            Nil            4,833 
                       ------------  ---------  --------------  -------------  --------------- 
         Nigel 
          Goldsmith      29/07/2015    3 years      28/07/2025           0.10           62,500 
                       ------------  ---------  --------------  -------------  --------------- 
         Nigel 
          Goldsmith      22/02/2018    3 years      22/02/2028            Nil           80,000 
                       ------------  ---------  --------------  -------------  --------------- 
         Nigel 
          Goldsmith      26/06/2020    3 years      26/06/2030            Nil           74,000 
                       ------------  ---------  --------------  -------------  --------------- 
         Nigel 
          Goldsmith      16/04/2021    3 years      01/01/2031            Nil            3,031 
                       ------------  ---------  --------------  -------------  --------------- 
         Nigel 
          Goldsmith      27/09/2021    3 years      27/09/2031            Nil           25,000 
                       ------------  ---------  --------------  -------------  --------------- 
         Nigel 
          Goldsmith      02/03/2022    3 years      01/01/2032            Nil            2,165 
                       ------------  ---------  --------------  -------------  --------------- 
 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the party to the offer making the disclosure or any person acting 
  in concert with it: 
  Irrevocable commitments and letters of intent should not be included. If there are no such 
  agreements, arrangements or understandings, state "none" 
 None 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the party 
  to the offer making the disclosure, or any person acting in concert with it, and any other 
  person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
 None 
 
   (c)        Attachments 

Are any Supplemental Forms attached?

 
 Supplemental Form 8 (Open Positions)   NO 
 Supplemental Form 8 (SBL)              NO 
                                       --- 
 
 
 Date of disclosure:    5 September 2023 
 Contact name:          Nigel Goldsmith, Chief Financial Officer 
                       ----------------------------------------- 
 Telephone number:      +44 17 8582 5608 
                       ----------------------------------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FEEUPUAABUPWGQA

(END) Dow Jones Newswires

September 05, 2023 13:00 ET (17:00 GMT)

Instem (LSE:INS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Instem Charts.
Instem (LSE:INS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Instem Charts.